Adalimumab, a novel anti-tumor necrosis factor-α antibody in a child with refractory Crohn's disease

被引：23
|
作者：
Mian, S
Baron, H
机构：
[1] Pediat Gastroenterol & Nutr Assoc, Las Vegas, NV 89109 USA
[2] Univ Nevada, Sch Med, Dept Pediat, Reno, NV 89557 USA
来源：
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2005年 / 41卷 / 03期
关键词：
D O I：
10.1097/01.mpg.0000169275.86308.b0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：357 / 359
页数：3
相关论文
共 50 条
  • [1] Tacrolimus Salvage in Anti-Tumor Necrosis Factor Antibody Treatment-Refractory Crohn's Disease
    Gerich, Mark E.
    Pardi, Darrell S.
    Bruining, David H.
    Kammer, Patricia P.
    Becker, Brenda D.
    Tremaine, William T.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : 1107 - 1111
  • [2] Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
    Hanauer, SB
    Sandborn, WJ
    Rutgeerts, P
    Fedorak, RN
    Lukas, M
    Macintosh, D
    Panaccione, R
    Wolf, D
    Pollack, P
    GASTROENTEROLOGY, 2006, 130 (02) : 323 - 332
  • [3] Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti-Tumor Necrosis Factor-α Agents
    Kestens, Christine
    van Oijen, Martijn G. H.
    Mulder, Charlotte L. J.
    van Bodegraven, Ad A.
    Dijkstra, Gerard
    de Jong, Dirk
    Ponsioen, Cyriel
    van Tuyl, Bas A. C.
    Siersema, Peter D.
    Fidder, Herma H.
    Oldenburg, Bas
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (07) : 826 - 831
  • [4] CDP571, a humanized anti-tumor necrosis factor-α monoclonal antibody in pediatric Crohn's disease
    Mamula, P
    Cohen, SA
    Ferry, GD
    Kirschner, BS
    Winter, HS
    Innes, A
    Patel, J
    Baldassano, RN
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) : 723 - 730
  • [5] Refractory Central Nervous System Vasculitis and Gastrocnemius Myalgia Syndrome in Crohn's Disease Successfully Treated with Anti-Tumor Necrosis Factor-α Antibody
    Ullrich, Sebastian
    Schinke, Susanne
    Both, Markus
    Knop, Karl Christian
    Kirkiles-Smith, Nancy Coula
    Gross, Wolfgang Ludwig
    Lamprecht, Peter
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 38 (05) : 337 - 347
  • [6] Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-α Monoclonal Antibody Treatment for Crohn's Disease
    Matsuoka, Katsuyoshi
    Kanai, Takanori
    DIGESTION, 2013, 88 (01) : 17 - 19
  • [7] Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab
    Tatò, F
    Rieger, J
    Hoffmann, U
    INTERNATIONAL ANGIOLOGY, 2005, 24 (03) : 304 - 307
  • [8] The Role of Oxidative Stress in Anti-tumor Necrosis Factor Antibody Treatment in Crohn's Disease
    Kupcova, V.
    Turecky, L.
    Uhlikova, E.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (30) : 5226 - 5231
  • [9] Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-α antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease
    Hommes, DW
    van Dullemen, HM
    Levi, M
    Van der Ende, A
    Woody, J
    Tytgat, GNJ
    van Deventer, SJH
    HAEMOSTASIS, 1997, 27 (06) : 269 - 277
  • [10] Anti-Tumor Necrosis Factor Nonresponders in Crohn's Disease: Therapeutic Strategies
    Louis, E.
    Belaiche, J.
    Reenaers, C.
    DIGESTIVE DISEASES, 2009, 27 (03) : 351 - 357
12345